Cardiovascular disease. Does inflammation cut to the heart of the matter?
about
sameAs
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveEndothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumParticle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular diseaseParticle-induced pulmonary acute phase response correlates with neutrophil influx linking inhaled particles and cardiovascular riskDifferences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide.Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.Biomarkers and HIV-associated cardiovascular disease.DNA damage following pulmonary exposure by instillation to low doses of carbon black (Printex 90) nanoparticles in mice.Development potential of rifalazil.Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFα signaling revealed by integrated genomic analyses.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Relationships and Inflammation across the Lifespan: Social Developmental Pathways to Disease.Wound healing and inflammation: embryos reveal the way to perfect repairPathophysiology and diagnostic value of urinary trypsin inhibitors.HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generationPlasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids.The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407.Effect of n-3 fatty acid ratio and dose on clinical manifestations, plasma fatty acids and inflammatory mediators in dogs with pruritus.Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes.Editorial: dose-dependent ZnO particle-induced acute phase response in humans warrants re-evaluation of occupational exposure limits for metal oxides.Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in a rat endometriosis model.
P2860
Q24594814-4112738B-A5F9-4942-ACAB-C8D3D9D35DF5Q28219326-4A58EBCD-69D0-48B1-B350-5FACE054F8EEQ28385471-A01777AC-3F9B-42F5-AA0A-66CD650E226AQ28386194-336567D8-3ECE-4E15-9699-BA755002EF1CQ33751656-26A62801-5A39-4712-9A09-2D1A70DA7F13Q34188034-5FBF5D33-F334-4036-8704-2014D18C547EQ34335486-869F488C-9F78-4674-968F-944B5B7E30EEQ35035345-B67DEC15-EDCE-4666-B483-F580D955F99EQ35056073-7909831F-F404-4097-9AA2-C27681DA55F7Q35101212-99AAD9AC-C532-4E29-B91A-896A9109082EQ35118257-C450863D-AD61-46DA-AD36-B9D9000EDAA6Q35572794-55BAC99E-48BD-470D-A3EC-D5A62B53A732Q35855738-F3DE5F1E-380A-48A5-839F-D50B6F284C74Q36011173-BDD79A21-AE7F-4AD0-9284-342CBC8D82F1Q37310421-B5036F49-B78A-4583-9827-96A95CA4CA90Q40083837-37D5B46E-983F-43F0-A380-337F211BA15DQ40673400-6F0B43DA-684C-45CC-8A91-209196614B1EQ40867788-5F09EF45-AD7D-4CB0-ABE9-AFB02C0A692DQ44380481-AB9578E3-5D39-4919-B3BE-4E45F7DD4257Q44700371-B78072F1-6722-4FF5-AF48-FA25724BC16EQ50077354-A2B8502A-CE28-422C-BC25-87DCDBB21179Q51135178-BC7E1DCB-40B6-4941-AD45-EF759316F1F1
P2860
Cardiovascular disease. Does inflammation cut to the heart of the matter?
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@ast
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@en
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@nl
type
label
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@ast
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@en
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@nl
prefLabel
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@ast
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@en
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@nl
P1433
P1476
Cardiovascular disease. Does inflammation cut to the heart of the matter?
@en
P2093
Gary Taubes
P356
10.1126/SCIENCE.296.5566.242
P407
P577
2002-04-12T00:00:00Z